Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label Extension Study to Assess the Long-term Safety and Efficacy of Mipomersen in Subjects With Familial Hypercholesterolemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00477594
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:26.409130+00:00
Published At
2013-04-05T00:00:00+00:00
Record Updated At
2016-09-09
Results Posted At
2013-04-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lipid Metabolism, Inborn Errors", "Hypercholesterolemia, Autosomal Dominant", "Hyperlipidemias", "Metabolic Diseases", "Hyperlipoproteinemia Type II", "Metabolism, Inborn Errors", "Genetic Diseases, Inborn", "Infant, Newborn, Diseases", "Metabolic Disorder", "Congenital Abnormalities", "Hypercholesterolemia", "Hyperlipoproteinemias", "Dyslipidemias", "Lipid Metabolism Disorders"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-09-09"
protocolSection.identificationModule.nctId
"NCT00477594"
protocolSection.identificationModule.officialTitle
"An Open-Label Extension Study to Assess the Long-term Safety and Efficacy of Mipomersen in Subjects With Familial Hypercholesterolemia"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2013-04-05"

Study condition terms

  • Lipid Metabolism, Inborn Errors (protocolSection.conditionsModule.conditions)
  • Hypercholesterolemia, Autosomal Dominant (protocolSection.conditionsModule.conditions)
  • Hyperlipidemias (protocolSection.conditionsModule.conditions)
  • Metabolic Diseases (protocolSection.conditionsModule.conditions)
  • Hyperlipoproteinemia Type II (protocolSection.conditionsModule.conditions)
  • Metabolism, Inborn Errors (protocolSection.conditionsModule.conditions)
  • Genetic Diseases, Inborn (protocolSection.conditionsModule.conditions)
  • Infant, Newborn, Diseases (protocolSection.conditionsModule.conditions)
  • Metabolic Disorder (protocolSection.conditionsModule.conditions)
  • Congenital Abnormalities (protocolSection.conditionsModule.conditions)
  • Hypercholesterolemia (protocolSection.conditionsModule.conditions)
  • Hyperlipoproteinemias (protocolSection.conditionsModule.conditions)
  • Dyslipidemias (protocolSection.conditionsModule.conditions)
  • Lipid Metabolism Disorders (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.